Dexfenfluramine and norfenfluramine: Comparison of mechanism of action in feeding and brain Fos-ir studies

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 278, Issue 2 47-2, 2000, Pages

  Rowland, Neil E ^a,b   Roth, Jonathan D ^a   McMullen, Megan R ^a   Patel, Aashish ^a   Cespedes, Anna T ^a  

^a University of Florida ^*  (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

5,7 dihydroxytryptamine; Anorexia; Caudate nucleus; Cerebral cortex; Fos immunoreactivity; Median preoptic nucleus; P chlorophenylalanine; Paraventricular hypothalamus; Serotonin; Serotonin receptor subtypes; Supraoptic nucleus

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 5,7 DIHYDROXYTRYPTAMINE; DEXFENFLURAMINE; FENCLONINE; FLUOXETINE; NORFENFLURAMINE; SEROTONIN; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; BRAIN; BRAIN CORTEX; CAUDATE NUCLEUS; DRUG MECHANISM; FEEDING BEHAVIOR; FEMALE; IMMUNOREACTIVITY; MALE; NONHUMAN; PREOPTIC AREA; PRIORITY JOURNAL; RAT; RECEPTOR SENSITIVITY; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS;

EID: 0034094728     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2000.278.2.r390     Document Type: Article

References (44)

1. Borroni, E., A. Ceci, S. Garattini, and T. Mennini. Differences between d-fenfluramine and d-norfenfluramine in serotonin presynaptic mechanisms. J. Neurochem. 40: 891-893, 1983.
2. Carlton, J., and N. E. Rowland. Anorexia and brain serotonin: development of tolerance to the effects of fenfluramine and quipazine in rats with serotonin-depleting lesions. Pharmacol. Biochem. Behav. 20: 739-745, 1984.
3. 2+-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine. Br. J. Pharmacol. 121: 1735-1743, 1997.
4. Currie, P. J., D. V. Coscina, and P. J. Fletcher. Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine. Brain Res. 800: 62-68, 1998.
5. 2C receptor gene on meal patterns and on hypophagia induced by D-fenfluramine. Soc. Neurosci. Abstr. 23: 514, 1997.
6. Fletcher, P. J. Increased food intake in satiated rats induced by the 5-HT antagonists methysergide, metergoline and ritanserin. Psychopharmacology 96: 237-242, 1988.
7. Gibson E. L., A. J. Kennedy, and G. Curzon. d-Fenfluramine and d-norfenfluramine-induced hypophagia: differential mechanisms and involvement of postsynaptic 5-HT receptors. Eur. J. Pharmacol. 242: 83-90, 1993.
8. Gobbi, M., A. Parazzoli, and T. Mennini. In vitro studies on the mechanism by which (+)-norfenfluramine induces serotonin and dopamine release from the vesicular storage pool. Naunyn-Schmiedebergs Arch. Pharmacol. 358: 323-327, 1998.
9. Grignashi, G., and R. Samanin. Role of 5HT receptors in the effect of d-fenfluramine on feeding patterns. Eur. J. Pharmacol. 212: 287-289, 1992.
10. Grill, H. J., J. C. K. Donahey, L. King, and J. M. Kaplan. Contribution of caudal brainstem to d-fenfluramine anorexia. Psychopharmacology 130: 375-381, 1997.
11. Guerra, M. J., I. Liste, and J. L. Labandeira-Garcia. Interaction between the serotonergic, dopaminergic, and glutamatergic systems in fenfluramine-induced Fos expression in striatal neurons. Synapse 28: 71-82, 1998.
12. Hollister, A. S., G. N. Ervin, B. R. Cooper, and G. R. Breese. The roles of monoamine neural systems in the anorexia induced by (+)-amphetamine and related compounds. Neuropharmacology 14: 715-723, 1975.
13. Javed, A., L. D. van de Kar, and T. S. Gray. p-Chlorophenylalanine and fluoxetine inhibit D-fenfluramine-induced Fos expression in the paraventricular nucleus, cingulate cortex and frontal cortex but not in other forebrain and brainstem regions. Brain Res. 774: 94-105, 1997.
14. Javed, A., L. D. van de Kar, and T. S. Gray. The 5-HT1A and 5-HT2A/2C receptor antagonists WAY-100635 and ritanserin do not attenuate D-fenfluramine-induced Fos expression in the brain. Brain Res. 791: 67-74, 1998.
15. Kaplan, J. M., S. Song, and H. J. Grill. Serotonin receptors in the caudal brainstem are necessary and sufficient for the anorectic effect of peripherally administered mCPP. Psychopharmacology 137: 43-49, 1998.
16. 1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia. Br. J. Pharmacol. 103: 2016-2020, 1991.
17. Kirby, L. G., D. S. Kreiss, A. Singh, and I. Lucki. Effect of destruction of serotonin neurons on basal and fenfluramine-induced serotonin release in striatum. Synapse 20: 99-105, 1995.
18. LaHoste, G. J., and J. F. Marshall. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. Synapse 12: 14-26, 1992.
19. LaHoste, G. J., J. Yu, and J. F. Marshall. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. Proc. Natl. Acad. Sci. USA 90: 7451-7455, 1993.
20. Lawton, C. L., and J. E. Blundell. 5-HT and carbohydrate suppression: effects of 5-HT antagonists on the action of d-fenfluramine and DOI. Pharmacol. Biochem. Behav. 46: 349-360, 1993.
21. 1B) agonist, CP-93,129, into the parabrachial nucleus potently and selectively reduces food intake in rats. Psychopharmacology 136: 304-307, 1998.
22. 2/1C receptor activation causes a localized expression of the immediate-early gene c-fos in rat brain: evidence for involvement of dorsal raphe nucleus projection fibers. Neuroscience 53: 457-463, 1993.
23. Li, B.-H., and N. E. Rowland. Dexfenfluramine induces Fos-like immunoreactivity in discrete brain regions in rats. Brain Res. Bull. 31: 43-48, 1993.
24. Li, B.-H., and N. E. Rowland. Effect of chronic dexfenfluramine on Fos in rat brain. Brain Res. 728: 188-192, 1996.
25. Li, B.-H., A. C. Spector, and N. E. Rowland. Reversal of dexfenfluramine-induced anorexia and c-fos/c-jun expression by lesion in the lateral parabrachial nucleus. Brain Res. 640: 255-267, 1994.
26. Lightowler, S., M. Wood, T. Brown, A. Glen, T. Blackburn, I. Tulloch, and G. Kennett. An investigation of the mechanism responsible for fluoxetine-induced hypophagia in rats. Eur. J. Pharmacol. 296: 137-143, 1996.
27. Lucas, J. J., A. Yamamoto, K. Scearce-Levie, F. Saudou, and R. Hen. Absence of fenfluramine-induced anorexia and reduced c-fos induction in the hypothalamus and central amygdaloid nucleus of serotonin 1B receptor knock-out mice. J. Neurosci. 18: 5537-5544, 1998.
28. Lucki, I., M. S. Kreider, and K. J. Simansky. Reduction of feeding behavior by the serotonin uptake inhibitor sertraline. Psychopharmacology 96: 289-295, 1988.
29. Moorman, J. M., A. Jackson, D. G. Grahame-Smith, and R. A. Leslie. Induction of c-fos in rat forebrain by pharmacological manipulation of 5-hydroxytryptamine levels. Neuroscience 68: 1089-1096, 1995.
30. Oluyomi, A. O., E. L. Gibson, A. M. C. Barnfield, and G. Curzon. d-Fenfluramine and d-norfenfluramine hypophagias do not require increased hypothalamic 5-hydroxytryptamine release. Eur. J. Pharmacol. 264: 111-115, 1994.
31. Raiteri, M., G. Bonnano, and F. Vallebuona. In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia. J. Pharmacol. Exp. Ther. 273: 643-649, 1995.
32. Richard, D., S. Rivest, and C. Rivier. The 5-hydroxytryptamine agonist fenfluramine increases Fos-like immunoreactivity in the brain. Brain Res. 594: 131-137, 1992.
33. Rowland, N. E. Brain mechanisms of mammalian fluid homeostasis: insights from the use of immediate early gene mapping. Neurosci. Biobehav. Rev. 23: 49-63, 1998.
34. Rowland, N. E., and J. Carlton. Neurobiology of an anorectic drug: fenfluramine. Prog. Neurobiol. 27: 13-62, 1986.
35. Rowland, N. E., and J. Carlton. Dexfenfluramine: effects on food intake in various animal models. Clin. Neuropharmacol. 11, Suppl. 1: S33-S50, 1988.
36. Rowland, N. E., A. N. Kalehua, B.-H. Li, S. L. Semple-Rowland, and W. J. Streit. Loss of serotonin uptake sites and immunoreactivity in rat cortex after dexfenfluramine cocur without parallel glial cell reactions. Brain Res. 624: 35-43, 1993.
37. Rowland, N. E., and K. L. Robertson. Comparison of effect of serotonin agonists in suppression of food, water, and sodium intake in rats. Soc. Neurosci. Abstr. 25: 1360, 1999.
38. 2 receptors do not play an important role in the anorectic activity of D-fenfluramine in the rat. Neuropharmacology 28: 465-469, 1989.
39. Semple-Rowland, S. L., A. Mahatme, and N. E. Rowland. Effects of dexfenfluramine or 5,7-dihydroxytryptamine on tryptophan hydroxylase and serotonin transporter mRNAs in rat dorsal raphe. Mol. Brain Res. 41: 121-127, 1996.
40. Simansky, K. J. Serotonergic control of the organization of feeding and satiety. Behav. Brain Res. 73: 37-42, 1996.
41. 2C receptors. Nature 374: 542-546, 1995.
42. Tohyama, I., M. Kameyama, and H. Kimura. Quantitative morphometric analysis of two types of serotonin-immunoreactive nerve fibres differentially responding to p-chlorophenylalanine treatment in the rat brain. Neuroscience 26: 971-991, 1988.
43. 2C receptor in mediating d-fenfluramine and d-norfenfluramine hypophagia (Abstract). Appetite 33: 271, 1999.
44. Zhou, F. C., Y. Xu, S. Bledsoe, R. Lin, and M. R. Kelley. Serotonin transporter antibodies: production, characterization and localization in the brain. Mol. Brain Res. 43: 267-278, 1996.